Biotech · Private company
Tobira Therapeutics, Inc.
Track this companyFree. Adds Tobira Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- CenicrivirocPhase 3 · Nonalcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
- Cenicriviroc 150 mgPhase 2 · Prediabetic StateClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH)PHASE3 · TERMINATED · started Apr 5, 2017ClinicalTrials.gov NCT03028740 · fetched Nov 12, 2026
- Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic SteatohepatitisPHASE2 · TERMINATED · started Feb 14, 2017ClinicalTrials.gov NCT03059446 · fetched Nov 12, 2026
- ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or Type 2 Diabetes Mellitus (T2DM) and Suspected NAFLDPHASE2 · COMPLETED · started Jul 17, 2015ClinicalTrials.gov NCT02330549 · fetched Nov 12, 2026
- Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver FibrosisPHASE2 · COMPLETED · started Sep 18, 2014ClinicalTrials.gov NCT02217475 · fetched Nov 12, 2026